Tharimmune
Tharimmune53About
What does Tharimmune do?
Canton Strategic Holdings is the first publicly traded company leveraging Canton Coin and supporting the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. They operate a Super Validator for the Network, ensuring secure transactions, and are focused on the tokenization of real-world assets. The company serves institutional investors and participants in the financial markets.
What is Tharimmune's revenue?
StartupHub estimates Tharimmune's annual revenue at $2.2M (range $1.2M to $3.8M, 65% confidence), based on comparable companies in the sector.
What is Tharimmune's valuation?
StartupHub estimates Tharimmune's effective valuation at $2.1B (range $1.4B to $3.2B, 20% confidence), based on comparable companies in the sector.
How much funding has Tharimmune raised?
Tharimmune has raised a total of $540M in funding.
Where is Tharimmune headquartered?
Tharimmune is headquartered in Cambridge, United States.
When was Tharimmune founded?
Tharimmune was founded in 2017.
What industry does Tharimmune operate in?
Tharimmune operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Immunotherapy.
How many employees does Tharimmune have?
Tharimmune has approximately 13 people on record.
No comments yet. Be the first to share your take.